4th World Psoriasis & Psoriatic Arthritis Conference gives patients hope for the future

International Federation of Psoriasis Associations arranges conference aimed at increasing understanding of complex diseases psoriasis and psoriatic arthritis in order to improve patient outcomes

(Stockholm, February 9)
This summer world-leading experts will be gathering in Stockholm to discuss the current frontline in clinical research and pathophysiological understanding of all aspects related to the serious chronic diseases psoriasis and psoriatic arthritis.

Arranged by the International Federation of Psoriasis Associations, IFPA, this fourth conference of its kind recognizes the many great and recent advances that have been made within the fields of psoriasis and psoriatic arthritis. The multidisciplinary sessions will cover subjects such as psoriasis as a multi-organ disease and give an international outlook on psoriasis and psoriatic arthritis treatment and care and will provide delegates with the latest research and facts on biomarkers and diagnostics, genetics of psoriasis and psoriatic arthritis, long-term treatment with available therapies and treatments in development.

Prof.Dr. Peter van de Kerkhof of Radboud University Nijmegen Medical Centre , President of the 4th World Psoriasis & Psoriatic Arthritis Conference and Chairman of its Scientific Executive Committee, comments:
“Our understanding of psoriasis as a complex inflammatory immune-mediated disease with significant comorbidities has made important progress over the last few years. New insights have been obtained into the pathogenesis of psoriasis and psoriatic arthritis, which are revolutionizing the treatment of the patient of today and tomorrow. The 4th World Psoriasis & Psoriatic Arthritis Conference will give us an excellent opportunity to discuss these significant breakthroughs with colleagues and patient leaders from all over the world and will hopefully help improve the situation for the millions of people who suffer from these chronic diseases.”

The World Psoriasis & Psoriatic Arthritis Conferences, initiated by IFPA in 2006, are unique in that they invite dermatologists, rheumatologists, general practitioners, allied health professionals and patient leaders from all over the world to participate; creating a platform for education, networking and fostering research within psoriasis and psoriatic arthritis, with dedicated focus on the patients.

“That psoriasis is a noncommunicable disease with a significant disease burden was formally recognized by a WHO resolution in May 2014”, says Lars Ettarp, President of IFPA. “It is of the highest importance for IFPA and its member organizations to ensure that the disease is understood correctly by policy makers and healthcare professionals and that the necessary steps are taken to provide people with psoriasis with the treatment and care they need and deserve. The World Psoriasis & Psoriatic Arthritis Conferences are a very important part of the strategic work IFPA is doing to educate both the providers and recipients of this care and we hope to see doctors, nurses, researchers and patient leaders from all over the globe in Stockholm this summer.”


About the 4th World Psoriasis & Psoriatic Arthritis Conference 2015 – quick facts
Conference name
: 4th World Psoriasis & Psoriatic Arthritis Conference 2015
Theme: “Psoriasis – new insights and innovations”
Dates: July 8 – 11, 2015
Venue: Stockholm Waterfront Congress Centre, Stockholm, Sweden
Target group: Dermatologists, rheumatologists and general practitioners and allied health professionals with an interest in psoriasis and psoriatic arthritis
Website: www.ifpaworldconference.com
Press registration: Fully accredited members of the press are invited to attend the 4th World Psoriasis & Psoriatic Arthritis Conference. Registration as an accredited press member is complimentary. To apply, send an e-mail to ifpa@pso.se with the following information:
- A photography of your valid Press ID
- Name and URL of the journal you are working for
- The reason for attending the conference


About the International Federation of Psoriasis Associations, IFPA
The International Federation of Psoriasis Associations, IFPA, is the non-profit umbrella organization gathering the majority of national and regional psoriasis patient associations. Today, IFPA has more than 50 member associations covering all regions of the world. IFPA’s mission is to be the unifying global voice of all psoriasis associations, supporting, strengthening and promoting their cause at an international level. You can read more about IFPA’s activities on www.ifpa-pso.org.

Contact
For more information about the conference, please contact Barbra Bohannan, IFPA Head of Operations and Strategic Communications and Secretary of the Scientific Executive Committee of the 4th World Psoriasis & Psoriatic Arthritis Conference 2015.
Email: barbra.bohannan@pso.se

Telephone: +46 8 556 109 15

Tags:

About Us

The International Federation of Psoriasis Associations, IFPA, is a non-profit umbrella organization that gathers psoriasis patient associations from around the world. Today IFPA has 54 member associations covering all regions of the world. IFPA unites psoriasis associations so that their global campaign for improved medical care, greater public understanding and increased research will improve the lives of the more than 125 million people who live with psoriasis and/or psoriatic arthritis. IFPA is actively campaigning for recognition of psoriasis as a serious, noncommunicable disease by the World Health Organization’s member states. You can read more about IFPA, our members and our activities on our website www.ifpa-pso.org.

Quotes

Our understanding of psoriasis as a complex inflammatory immune-mediated disease with significant comorbidities has made important progress over the last few years. New insights have been obtained into the pathogenesis of psoriasis and psoriatic arthritis, which are revolutionizing the treatment of the patient of today and tomorrow.
Prof.Dr. Peter van de Kerkhof, President 4th World Psoriasis & Psoriatic Arthritis Conference
It is of the highest importance for IFPA and its member organizations to ensure that the disease is understood correctly by policy makers and healthcare professionals and that the necessary steps are taken to provide people with psoriasis with the treatment and care they need and deserve.
Lars Ettarp, President IFPA